Gangadharan Manjunath
Known title: VP, Chief Accounting OfficerCIK: 0001805055
Associated companies
Transaction History
| CVSA | ▼ Sell | Open Market | 1,802 | $247K | 8/27/2026 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 188 | $25K | 8/23/2026 | View on chart |
| CVSA | ▲ Buy | Grant | 1,050 | $139K | 8/23/2026 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 308 | $41K | 8/23/2026 | View on chart |
| CVSA | ▲ Buy | Grant | 1,500 | $199K | 8/23/2026 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 440 | $58K | 8/23/2026 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 426 | $54K | 5/18/2026 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 94 | $9K | 11/13/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 890 | $86K | 11/12/2025 | View on chart |
| CVSA | ▼ Sell | Open Market | 944 | $128K | 8/27/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 194 | $26K | 8/24/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 796 | $107K | 8/24/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 2,717 | $366K | 8/24/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 182 | $25K | 8/23/2025 | View on chart |
| CVSA | ▼ Sell | Open Market | 966 | $127K | 5/21/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 414 | $56K | 5/18/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 960 | $86K | 11/13/2024 | View on chart |
| CVSA | ▼ Sell | Open Market | 944 | $71K | 8/28/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 194 | $15K | 8/24/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 182 | $14K | 8/23/2024 | View on chart |
| CVSA | ▼ Sell | Open Market | 946 | $62K | 5/22/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 434 | $28K | 5/18/2024 | View on chart |
| CVSA | ▼ Sell | Open Market | 1,418 | $62K | 8/28/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 194 | $8K | 8/24/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 1,920 | $83K | 8/23/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 448 | $19K | 5/18/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 2,040 | $81K | 8/24/2022 | View on chart |
| CVSA | ▲ Buy | Grant | 5,520 | $175K | 5/18/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Covista receives mixed analyst coverage and rating update
Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.
Covista receives mixed analyst coverage and rating update. Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.